Private company · employee equity guide

PPathAI logo

What is PathAI stock worth?

PathAI's mission is to improve patient outcomes with AI-powered pathology. Our platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine learning. We are a company of diverse employees with a wide range of backgrounds and experiences. Our world class team is passionate about solving challenging problems and making a huge impact. Our office is located in the heart of Fenway. PathAI was recently voted one of BBJ's Best Places to Work!

Estimated share price

Members onlySee the real chart, freeNo card. Takes about a minute.

PathAI has an observed estimated price: most recent data 2026-09-15, daily history back to 2022-09-21.

Estimated from live trades and accepted bids across employer liquidity programs, institutional trades, broker trades, and pre-IPO marketplaces. Private shares are illiquid and transfer-restricted; estimates are educational, not an offer or advice. The preview above is blurred and illustrative. How this is calculated

About PathAI

Employees
284
Founded
2016
Industry
Software Development, Technology, Information and Internet, Technology, Information and Media
Website
pathai.com

Weighing a PathAI offer?

Upload the offer letter to see what the equity is approximately worth at today's estimated price. No account needed.

X-ray an offer

Leaving PathAI? Mind the window.

If you hold options, leaving usually starts a post-termination exercise clock, often 90 days. Miss it and vested options can expire worthless; exercise blindly and you may owe real money (including possible AMT) on shares you can't yet sell. Neither panic nor autopilot is a plan. Knowing your window, your exercise cost, and the current estimated price is.

Track my window freeUpload your grant doc. We extract the window and set the reminders.

PathAI in the last 12 months

  • 1 acquisition (as buyer)

Covered by 7 distinct publications since 2025-08-21.

PathAI news timeline

PathAI equity, answered plainly

Is PathAI a public company?

No. PathAI is privately held, which is exactly why its share price doesn't show up in your brokerage app. The company (founded in 2016, operating in software development, with roughly 284 employees) remains private even at that scale. Its shares still change hands between eligible buyers and sellers on the secondary market, producing an observable estimated price.

What is PathAI's stock price?

PathAI has an observed estimated share price from secondary-market activity, updated as new data is observed. Its observed price history runs back to 2022-09-21. ExitCue members see the current estimate and its full history free, along with what their own grants are approximately worth at that price.

Can you sell PathAI stock before an IPO?

Sometimes. Private-share sales depend on PathAI's transfer restrictions, rights of first refusal, and whether the company runs tender offers or permits secondary sales. Your grant documents and the company's policies govern, but "hard to sell today" is not the same as "worth zero."

What happens to my PathAI options if I leave?

Most option grants have a post-termination exercise window, commonly 90 days, sometimes longer, after which unexercised options expire worthless. The exact terms are in your grant documents. ExitCue reads those documents, tracks the deadline, and reminds you before the window closes.

How much is my PathAI equity worth?

Multiply what you hold by the estimated share price, separating vested from unvested, and netting out strike prices for options. That's precisely the arithmetic ExitCue does for you, continuously, at the current observed estimate. It's an educational estimate, not a guarantee, and a far better anchor than the $0 the internet suggests.

What's the difference between PathAI's 409A valuation and what its shares trade at?

The 409A is a tax-compliance appraisal, usually conservative, used to set option strike prices. Secondary-market pricing reflects what buyers and sellers actually agree to. The two frequently differ, which is why evaluating an offer on the 409A alone undersells (or oversells) it.

When will PathAI IPO?

Unless PathAI has publicly announced a listing, nobody knows, including the people who sound confident on forums. The practical upside of secondary markets is that you don't have to wait for an IPO to know approximately what the shares trade at.

Do my unvested PathAI RSUs count for anything?

Unvested equity isn't yours yet, but it has an estimable value and a schedule. Seeing vested and unvested value separately, in dollars at the current estimated price, turns "some RSUs" into a number you can plan around.

General educational information, not advice about your specific situation. Grant terms vary; your documents govern.

Work out what your PathAI equity is worth

These calculators take your own numbers and need no account.

New to this? Learn explains grant types, vesting and cliffs, and where an estimated share price comes from — in plain language.

Other private companies with observed prices

Company logos provided by Brandfetch.